Warning: Full spoilers follow for Daredevil: Born Again Episodes 1 and 2. Daredevil: Born Again Season 2 is officially coming to Disney+, and when it arrives, it’ll bring back Deborah Ann Woll ...

Suze Orman has surprisingly simple Social Security, retirement advice Bengals make Ja'Marr Chase the NFL's highest-paid non-QB, also sign Tee Higgins to massive deal, per reports How often should ...

A new docuseries about Karen Read’s highly publicized trial is coming to Investigation Discovery. “A Body in the Snow: The Trial of Karen Read” premieres on Investigation Discovery and MAX ...

Karen Read was willing to talk about why boyfriend John O’Keefe was found dead on a fellow Boston police officer’s front lawn in January 2022 even before her first trial in 2024 ended in a ...

When Russell’s first novel, Swamplandia!, first came out in 2011, no one mistook it for a young-adult novel. It was a finalist for the Pulitzer Prize. Russell had already been chosen as one of ...

Jake Carter and Karen Byrne have announced their engagement, seven years after they met while competing on Dancing with the Stars. The couple, who won the second series of the show in 2018, got ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest ...

Novo announced results from a new weight loss drug that failed to meet expectations. Despite the results, the company is still in a strong position to continue leading the weight loss space.

The director of a new documentary on the Karen Read case on Monday touted the “unprecedented” access the film crew had to the former financial analyst and her high-powered legal team during ...

Investigation Discovery's docuseries 'Body in the Snow' features Karen Read telling her full story for the first time ahead of her April 1 retrial for murder.

Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. Three months after missing that target in its first phase 3 CagriSema trial, the Danish drugmaker has fallen ...